CLGN insider transaction filings
CollPlant Biotechnologies Ltd — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-08. Screen CLGN transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Abelis Bar Berta — VP Legal | 1 | — | — | 1 |
| Rotem Eran — Deputy CEO and CFO | 1 | — | — | 1 |
Recent Form 4 filings — CollPlant Biotechnologies Ltd
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Abelis Bar Berta — VP Legal | Grant/award (A): 201,141 @ $0 | EDGAR |
| 2026-09-08 | 4 | Rotem Eran — Deputy CEO and CFO | Grant/award (A): 510,372 @ $0 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CLGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →